3 results
The primary objective is:1. to compare the biodistribution and uptake in DLBCL of 89Zirconium (89Zr)-ofatumumab and 89Zr-rituximab (visual and quantitative).The secondary objectives are: 1. to compare the biodistribution and uptake in DLBCL of 89Zr-…
"The primary objective of this study is to compare the clinical therapeutic effects of intravenous DP-b99 at adose of 1.0 mg/kg initiated within nine hours of stroke onset and administered daily over 2 hours for 4consecutive days versus placebo…
Primary: • To analyze the stability of the MHP using R.S.A to predict the long term survival.Secondary• To analyze the short term (1 year) safety of the MHP compared to the Stanmore hip replacement.• To analyze the short term (1 year) efficacy of…